UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The complexity of Raf-1 regulation

Current opinion in cell biology, 1997-04, Vol.9 (2), p.174-179

1997

Volltextzugriff (PDF)

Abstract P2-03-05: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-03-05

2017

Volltextzugriff (PDF)

Abstract P3-04-03: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 ( ERBB2 ) mutations in metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-04-03

2018

Volltextzugriff (PDF)

Abstract PD2-05: Inhibition of mutant HER2 results in synthetic lethality when combined with ER antagonists in ER+/HER2 mutant human breast cancer cells

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.PD2-05-PD2-05

2017

Volltextzugriff (PDF)

Abstract PD3-05: Co-occurring gain-of-function mutations in HER2 and HER3 cooperate to enhance HER2/HER3 binding, HER-dependent signaling, and breast cancer growth

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD3-05-PD3-05

2019

Volltextzugriff (PDF)

Abstract P3-05-05: Targeting tumor re-wiring by triple blockade of mTORC1, ERBB and ER signaling pathways in endocrine resistant breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-05-05

2016

Volltextzugriff (PDF)

Abstract P3-03-03: An acquired HER2 T798I gatekeeper mutation induces resistance to neratinib in a patient with HER2 mutant-driven breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P3-P3-03-03

2017

Volltextzugriff (PDF)

Abstract P1-13-08: Extended adjuvant neratinib/fulvestrant blocks ER/HER2 crosstalk and maintains complete responses of ER+/HER2+ tumors following treatment with chemotherapy and anti-HER2 therapy

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-13-08

2018

Volltextzugriff (PDF)

Abstract PD3-06: Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer: Updated results from the phase 2 SUMMIT trial

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD3-06-PD3-06

2019

Volltextzugriff (PDF)

Mammalian Raf-1 is activated by mutations that restore Raf signaling in Drosophila

The EMBO journal, 1997-04, Vol.16 (8), p.1953-1960

1997

Volltextzugriff (PDF)

Autoregulation of the Raf-1 Serine / Threonine Kinase

Proceedings of the National Academy of Sciences - PNAS, 1998-08, Vol.95 (16), p.9214-9219

1998

Volltextzugriff (PDF)

Abstract PD5-05: Neratinib for ERBB2 mutant, HER2 non-amplified, metastatic breast cancer: Preliminary analysis from a multicenter, open-label, multi-histology phase II basket trial

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.PD5-05-PD5-05

2016

Volltextzugriff (PDF)

Stk10, a New Member of the Polo-like Kinase Kinase Family Highly Expressed in Hematopoietic Tissue

The Journal of biological chemistry, 2003-05, Vol.278 (20), p.18221-18228

2003

Volltextzugriff (PDF)

Heat-shock protein-25/27 phosphorylation by the delta isoform of protein kinase C

Biochemical journal, 1998-06, Vol.332 ( Pt 3) (3), p.703-712

1998

Volltextzugriff (PDF)

Identification of Residues in the Cysteine-rich Domain of Raf-1 That Control Ras Binding and Raf-1 Activity

The Journal of biological chemistry, 1998-08, Vol.273 (34), p.21578-21584

1998

Volltextzugriff (PDF)

Identification of cAMP-dependent protein kinase holoenzymes in preantral- and preovulatory-follicle-enriched ovaries, and their association with A-kinase-anchoring proteins

Biochemical journal, 1999-12, Vol.344 Pt 2 (2), p.613-623

1999

Volltextzugriff (PDF)

Regulation of protein kinase C δ by estrogen in the MCF-7 human breast cancer cell line

Molecular and cellular endocrinology, 1999-02, Vol.148 (1), p.109-118

1999

Volltextzugriff (PDF)

Delta protein kinase-C in the rat ovary: estrogen regulation and localization

Endocrinology (Philadelphia), 1994-10, Vol.135 (4), p.1669-1678

1994

Volltextzugriff (PDF)

Regulation of PKC δ expression by estrogen and rat placental lactogen-1 in luteinized rat ovarian granulosa cells

Molecular and cellular endocrinology, 2000-04, Vol.162 (1), p.181-191

2000

Volltextzugriff (PDF)

Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency

Clinical pharmacokinetics, 1991-05, Vol.20 (5), p.420-427

1991

Volltextzugriff (PDF)

Regulation of δ protein kinase C during rat ovarian differentiation

Biochimica et biophysica acta, 1993-11, Vol.1179 (3), p.260-270

1993

Volltextzugriff (PDF)

Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: A prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency

American journal of kidney diseases, 1997-06, Vol.29 (6), p.897-906

1997

Volltextzugriff (PDF)

Cefadroxil kinetics in patients with renal insufficiency

Clinical pharmacology and therapeutics, 1979-05, Vol.25 (5part1), p.514-521

1979

Volltextzugriff (PDF)

The Pharmacokinetics and Colonic Tissue Concentrations of Cyclosporine After IV, Oral, and Enema Administration

Journal of clinical pharmacology, 1991-01, Vol.31 (1), p.76-80

1991

Volltextzugriff (PDF)

Estrogen modulates Ca2+-independent lipid-stimulated kinase in the rabbit corpus luteum of pseudopregnancy: identification of luteal estrogen-modulated lipid-stimulated kinase as protein kinase Cδ

The Journal of biological chemistry, 1992-08, Vol.267 (24), p.17061-17068

1992

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(149)
Buchkapitel
(2)

Sprache

Englisch
(151)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The complexity of Raf-1 regulation

Abstract P2-03-05: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients

Abstract P3-04-03: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 ( ERBB2 ) mutations in metastatic breast cancer patients

Abstract PD2-05: Inhibition of mutant HER2 results in synthetic lethality when combined with ER antagonists in ER+/HER2 mutant human breast cancer cells

Abstract PD3-05: Co-occurring gain-of-function mutations in HER2 and HER3 cooperate to enhance HER2/HER3 binding, HER-dependent signaling, and breast cancer growth

Abstract P3-05-05: Targeting tumor re-wiring by triple blockade of mTORC1, ERBB and ER signaling pathways in endocrine resistant breast cancer

Abstract P3-03-03: An acquired HER2 T798I gatekeeper mutation induces resistance to neratinib in a patient with HER2 mutant-driven breast cancer

Abstract P1-13-08: Extended adjuvant neratinib/fulvestrant blocks ER/HER2 crosstalk and maintains complete responses of ER+/HER2+ tumors following treatment with chemotherapy and anti-HER2 therapy

Abstract PD3-06: Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer: Updated results from the phase 2 SUMMIT trial

Mammalian Raf-1 is activated by mutations that restore Raf signaling in Drosophila

Autoregulation of the Raf-1 Serine / Threonine Kinase

Abstract PD5-05: Neratinib for ERBB2 mutant, HER2 non-amplified, metastatic breast cancer: Preliminary analysis from a multicenter, open-label, multi-histology phase II basket trial

Stk10, a New Member of the Polo-like Kinase Kinase Family Highly Expressed in Hematopoietic Tissue

Heat-shock protein-25/27 phosphorylation by the delta isoform of protein kinase C

Identification of Residues in the Cysteine-rich Domain of Raf-1 That Control Ras Binding and Raf-1 Activity

Identification of cAMP-dependent protein kinase holoenzymes in preantral- and preovulatory-follicle-enriched ovaries, and their association with A-kinase-anchoring proteins

Regulation of protein kinase C δ by estrogen in the MCF-7 human breast cancer cell line

Delta protein kinase-C in the rat ovary: estrogen regulation and localization

Regulation of PKC δ expression by estrogen and rat placental lactogen-1 in luteinized rat ovarian granulosa cells

Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency

Regulation of δ protein kinase C during rat ovarian differentiation

Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: A prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency

Cefadroxil kinetics in patients with renal insufficiency

The Pharmacokinetics and Colonic Tissue Concentrations of Cyclosporine After IV, Oral, and Enema Administration

Estrogen modulates Ca2+-independent lipid-stimulated kinase in the rabbit corpus luteum of pseudopregnancy: identification of luteal estrogen-modulated lipid-stimulated kinase as protein kinase Cδ

Suchergebnisse filtern